---
document_datetime: 2025-08-06 13:33:30
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zebinix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zebinix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.5549842
conversion_datetime: 2025-12-26 17:19:50.739117
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zebinix

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                           |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------|
| Variation type IB /  | C.I.11 Introduction of, or change(s) to, the | 05/08/2025                          | N/A                                         |                                  | To update the RMP to extend the due date of final |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000275829                     | obligations and conditions of a marketing authorisation, including the risk management plan - C.I.11.z Change in due date for category 1, 2 or 3 studies in the RMP and/or Annex II - Accepted To update the RMP to extend the due date of final report for the pregnancy exposure registry from December 2024 to February 2026. In addition the format was updated to comply with GVP module V (rev. 2).                                                                                                                                                                       |            |     | report for the pregnancy exposure registry from December 2024 to February 2026. In addition the format was updated to comply with GVP module V (rev. 2).   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000285690 | This was an application for a group of variations. A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted B.III.1.a European Pharmacopoeial Certificate of Suitability to the relevant Ph. Eur. Monograph - B.III.1.a.3 New certificate from a new manufacturer (replacement or addition) - Accepted | 25/07/2025 | N/A |                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

| Variation type IA_IN / EMA/VR/0000261032   | B.IV.1.a Addition or replacement of a device which is not an integrated part of the primary packaging - B.IV.1.a.1 Device with CE marking - Accepted   | 31/03/2025   | SmPC and PL   |
|--------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|---------------|